On Tuesday, Shares of Kansas City Southern (NYSE:KSU), gained 1.92% to $94.35.
Kansas City Southern, Vice President Investor Relations, William Galligan, will address two conferences in September. Interested investors not attending the conference may listen to the presentation via a simultaneous webcast on KCS’ website at www.kcsouthern.com. A link to the replay will be available following the event.
Mr. Galligan will address the Morgan Stanley Laguna Conference at 7:35 a.m. pacific daylight time on Thursday, September 17, 2015.
Headquartered in Kansas City, Mo., Kansas City Southern is a transportation holding company that has railroad investments in the U.S., Mexico and Panama. Its primary U.S. holding is The Kansas City Southern Railway Company, serving the central and south central U.S.
Kansas City Southern, through its auxiliaries, engages in the freight rail transportation business. It operates north/south rail route between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States.
Shares of Matador Resources Co (NYSE:MTDR), inclined 4.45% to $20.40, during its last trading session.
Matador Resources Company, declared a definitive agreement to sell a wholly-owned partner of Matador that owns certain natural gas gathering and processing assets in the Delaware Basin in Loving County, Texas, counting a cryogenic natural gas processing plant with about 35 million cubic feet per day of inlet capacity and about six miles of high-pressure gathering pipeline which connects a Matador-owned gathering system to the Processing Plant, to a partner of EnLink Midstream Partners, LP (ENLK) for cash consideration of about $143 million, subject to certain adjustments. The Processing Plant, which has been operational for about two weeks, is presently processing about 19 million cubic feet of natural gas per day.
In conjunction with the sale of the Loving County System, Matador will dedicate its current leasehold interests in Loving County following a 15-year, fixed-fee gathering and processing agreement and provide a volume commitment in exchange for priority one service. Matador can, at its option, dedicate any future leasehold acquisitions in Loving County to a partner of EnLink. In addition, Matador retains its natural gas gathering system up to a central delivery point and its other midstream assets in the area, counting oil and water gathering systems and salt water disposal wells. Finally, Matador has the ability to defer taxes related to the sale of the Loving County System through potential like-kind exchange transactions.
Upon closing, Matador anticipates to have over $500 million in liquidity counting nothing drawn against its revolving credit facility borrowing base of $375 million. Thus, the Company has ample liquidity to execute its capital plans in 2015 and 2016 and further capitalize on its current opportunities in the Delaware Basin. In addition, right away following the closing of the transaction, Matador anticipates its net debt to trailing 12-month Adjusted EBITDA ratio to be about 1.0x.
Matador Resources Company, an independent energy company, engages in the exploration, development, production, and acquisition of oil and natural gas resources in the United States.
At the end of Tuesday’s trade, Shares of Total System Services, Inc. (NYSE:TSS), gained 1.91% to $47.49.
Total System Services, declared that its board of directors has approved a quarterly cash dividend of $0.10 per share on TSYS common stock, payable October 1, 2015, to TSYS shareholders of record as of the close of business on September 17, 2015.
Total System Services, Inc. provides electronic payment processing services to banks and other financial institutions in the United States, Europe, Canada, Mexico, and internationally. It operates through four segments: North America Services, International Services, Merchant Services, and NetSpend.
Finally, Aquinox Pharmaceuticals Inc (NASDAQ:AQXP), ended its last trade with 3.19% gain, and closed at $18.14.
Aquinox Pharmaceuticals, declared that it intends to offer and sell, subject to market and other conditions, $75 million of its common stock in an underwritten public offering. In connection with this offering, Aquinox anticipates to grant the underwriters a 30-day option to purchase up to $11.25 million of additional shares of common stock. All of the shares are being offered by Aquinox. There can be no assurance as to whether or when the offering may be accomplished, or as to the actual size or terms of the offering.
Leerink Partners, Canaccord Genuity and Guggenheim Securities are acting as joint book-running managers for the offering. Needham & Company is acting as lead manager.
Aquinox Pharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics for diseases in the areas of inflammation and immuno-oncology.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
